glp-1 effects on muscle mass Weight loss with medicines does not result in a disproportionate loss of or function in obese mice and humans Study finds GLP-1 receptor agonists

After the shortage ended, 503B bulk compounding of tirzepatide is effectively blocked, and the FDA proposed in April 2026 to keep it off the 503B bulks list

As we age, carnitine levels tend to decrease making supplementation increasingly important

Others added stricter prior authorization requirements that made approval nearly impossible for obesity-only diagnoses

Glycine is an amino acid with calming effects on the digestive system, and some evidence suggests it reduces the nausea and GI distress associated with GLP-1 receptor agonists

From laboratory curiosity to broad-spectrum biomedical advances

Launches Pilot Program This Year France is not the first country to integrate obesity treatments into its public healthcare system